Stay updated on Porfimer Sodium PDT +/- Chemo in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Porfimer Sodium PDT +/- Chemo in Head and Neck Cancer Clinical Trial page.

Latest updates to the Porfimer Sodium PDT +/- Chemo in Head and Neck Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision label updated to v3.4.2 (replacing v3.4.1); no changes to study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoChange DetectedThe page displays an updated site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded a glossary to help users understand clinical trial terms. The page now includes updated QC metadata (Last Update Submitted that Met QC Criteria) and a new revision tag (Revision: v3.4.0), replacing older wording and format to improve clarity and perceived reliability of the study details.SummaryDifference0.2%

- Check37 days agoChange DetectedPage header updated to Revision: v3.3.4, replacing Revision: v3.3.3. This is a small metadata update to the page revision.SummaryDifference0.1%

- Check65 days agoChange DetectedNew York was added as a location under Locations. The page footer was updated to revision v3.3.3, and the HHS Vulnerability Disclosure link and the 'New York Locations' header were removed.SummaryDifference0.2%

- Check86 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page. No substantive changes to study details, eligibility criteria, or other content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Porfimer Sodium PDT +/- Chemo in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Porfimer Sodium PDT +/- Chemo in Head and Neck Cancer Clinical Trial page.